BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August

Day

• 1
• 2
• 3
• 5
• 6
• 7
• 8
• 9
• 10
• 12
• 13
• 14
• 15
• 16
• 17
• 19
• 20
• 21
• 22
• 23
• 24
• 26
• 27
• 28
• 29
• 30

• Press Releases

  Pulse Biosciences Enrolls First Patients in NANOPULSE-AF IDE Pivotal Clinical Study Evaluating nPulse™ Cardiac Catheter System for Atrial Fibrillation

  April 7, 2026

   · 

  7 min read
• Press Releases

  AIRNA Announces First Patient Dosed in Phase 1 Trial of AIR-001, Potential Best-in-Class RNA-Editing Therapy for Alpha-1 Antitrypsin Deficiency (AATD)

  April 7, 2026

   · 

  3 min read
• Press Releases

  Anavex Life Sciences to Present at the 25th Annual Needham Virtual Healthcare Conference

  April 7, 2026

   · 

  3 min read
• Press Releases

  Artelo Biosciences Regains Compliance with Nasdaq Listing Requirements

  April 7, 2026

   · 

  3 min read
• Press Releases

  Marvel Biosciences Secures Financial and Strategic Investment with 5 Horizon Ventures

  April 7, 2026

   · 

  6 min read
• Press Releases

  Plus Therapeutics Receives AMA PLA Code for CNSide® CSF Tumor Cell Enumeration Test, Advancing Reimbursement and U.S. Commercial Adoption

  April 7, 2026

   · 

  6 min read
• Press Releases

  Cognition Therapeutics to Present at Needham Virtual Healthcare Conference

  April 7, 2026

   · 

  6 min read
• Press Releases

  Palvella Therapeutics Appoints Accomplished Commercial Leader Kent Taylor as Senior Vice President of Sales

  April 7, 2026

   · 

  8 min read
• Press Releases

  CervoMed to Provide Neflamapimod Clinical Program Update and Participate in a Panel on Biomarkers at 2026 Lewy Body Dementia Association Annual Meeting

  April 7, 2026

   · 

  7 min read
• Press Releases

  NervGen Pharma Announces Successful End-of-Phase 2 Meeting and FDA Alignment on RESTORE, a Phase 3 Registrational Study of NVG-291 for Chronic Tetraplegia

  April 7, 2026

   · 

  10 min read